Mesa 2: diabetes mellitus tipo 1 y actividad física
DOI:
https://doi.org/10.47196/diab.v52i3Sup.123Palabras clave:
diabetes tipo 1, control glucémico, ejercicio, tecnología y diabetesResumen
En personas con diabetes tipo 1 (DM1) el ejercicio físico realizado en forma regular brindaría protección cardiovascular y tendría propiedades inmunomoduladoras pero la compleja interacción entre los efectos del ejercicio sobre el metabolismo glucídico y la terapia con insulina exógena supone un verdadero desafío. El ejercicio aeróbico por la contracción muscular disminuye la glucemia, conduce a un estado de hiperinsulinemia relativa y genera hipoglucemia al inicio o después del mismo mientras que el ejercicio anaeróbico se asocia a hiperglucemia por aumento de catecolaminas e incremento de lactato que favorece la neoglucogénesis hepática. El deterioro de la respuesta de hormonas contrarreguladoras existente en la DM1 amplifica la variabilidad glucémica y dificulta el control metabólico.
Existen guías y recomendaciones que buscan brindar un marco de seguridad para la prescripción de actividad física considerando la multiplicidad de disciplinas deportivas, la edad del paciente y la evaluación de las complicaciones crónicas de la diabetes antes del inicio de la misma. Entre las estrategias terapéuticas se encuentran la modulación con hidratos de carbono, la adecuación pre y pos ejercicio de la insulinoterapia y el control intensivo de glucemia y cetonas. Los nuevos infusores de insulina y monitoreo glucémico ofrecen la posibilidad del fraccionamiento y/o suspensión de dosis convirtiéndose en el gold standard entre los deportistas de alto rendimiento. A futuro modelos integrados con calculadoras de ejercicio inteligentes, capacidad predictiva y de “aprendizaje individualizado” (páncreas artificial) posibilitarán mantener la euglucemia y optimizar los beneficios del ejercicio como parte del tratamiento.
Citas
Tsinzas K, Mac Donald I. Endocrine and metabolic responses to exercise. En: Gallen I. Type 1 diabetes clinical management of the athlete. Springer USA 2012; 1-19.
Riddell MC, Gallen IW, Carmel E Smart CE, et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinology 2017; 1-3.
Rodríguez M. Nutrición y ejercicio en las personas con diabetes. Revista ALAD 2017; 7:40-49.
Colberg S, Laan R, Dassau E, Kerr D. Physical activity and type 1 diabetes: time for a rewire? Journal of Diabetes Science and Technology 2015; 9:609-618.
Galassetti P, Riddell MC. Exercise and type 1 diabetes. Comprehensive Physiology 2013; 3: 1309-36.
Ridell MC. The impact of type 1 diabetes on the physiologival responses to exercise. Type 1 Diabetes Clinical Management of the Athlete 2012; chapter 2. Doi: 10.1007/978-0-85729-754-9.
Zinman B, Murray FT, Vranic M, et al. Glucoregulation during moderate exercise in insulin treated diabetics. J Clin Endocrinol Metab 1977; 45:641-652.
Peter R, Luzio SD, Dunseath G, et al. Effects of exercise on the absorption of insulin glargine in patients with type 1 diabetes. Diabetes Care 2005; 28:560-565.
Riddell MC, Iscoe KE. Physical activity, sport and pediatric diabetes. Pediatr Diabetes 2006; 7: 60-70.
McDonald MJ. Postexercise late-onset hypoglycemia in insulindependent diabetic patients. Diabetes Care 1987;10:584-588.
Riddell MC, Bar-Or O, Ayub BV, et al. Glucose ingestion matched with total carbohydrate utilization attenuates hypoglycemia during exercise in adolescents with IDDM. Int J Sport Nutr 1999; 9:24-34.
Schiffrin A, Parikh S. Accommodating planned exercise in type I diabetic patients on intensive treatment. Diabetes Care 1985; 8:337-342.
Riddell MC, Perkins BA. Type 1 diabetes and vigorous exercise: applications of exercise physiology to patient management. Canadian Journal of Diabetes. 2006: 30, 1: 63-71.
Wasserman DH, Davis SN, Zinman B. Metabolism during exercise in health and diabetes. In: Ruderman N, Devlin JT, Schneider SH, Kriska A, Eds. Handbook of Exercise in Diabetes. Alexandria, VA: American Diabetes Association; 2002:63-100.
Galassetti PR, Iwanaga K, Crisostomo M, et al. Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls. Pediatr Diabetes 2006; 7: 16-24.
Guelfi KJ, Ratnam N, Smythe GA, et al. Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes. Am J Physiol Endocrinol Metab 2007; 292:865-870.
Iscoe KE, Campbell JE, Jamnik V, et al. Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technol Ther 2006;8 (6):627-35.
Taplin CE, Cobry E, Messer L, et al. Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes. J Pediatr 2010; 157(5):784-8.
Galassetti P, Tate D, Neill RA, et al. Effect of differing antecedent hypoglycemia on counterregulatory responses to subsequent exercise in type 1 diabetes. Diabetes 2003; 52: 349.
Galassetti P, Tate D, Neill RA, et al. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes. Am J Physiol Endocrinol Metab 2006; 290: 1109-1117.
Sigal R, Kenny G, Oh P, et al. Physical activity and diabetes. Canadian diabetes association clinical practice guidelines expert committee. Canadian diabetes association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32(1): 37-9.
Bergman BC, Howard D, Schauer Id. J Clin Endocrinol Metab 2012; 2011-3172.
Codella R, Terruzzi I, Luzi L. Why should people with type 1 diabetes exercise regularly? Acta Diabetol 2017. doi 10.1007/s00592-017-0978-x.
Brugnara L, Vinaixa M, Murillo S, et al. Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus. PLoS ONE. 2012; 7: 7.
Farrell L, Wood MJ, Martinovic M, et al. Metabolic signatures of exercise in human plasma. Sci Transl Med 2010; 2: 33-37.
Lee AD, Hansen PA, Schluter J, et al. Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle. Am J Physiol 1997 Sep; 273; 1:1082-7.
Riddell MC, Bar-or O, Hollidge-Horvat M, et al. Glucose ingestion and substrate utilization during exercise in boys with IDDM. J Appl Physiol 2000; 88: 1239-1246.
Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes 2002; 51, (Suppl 1): 271-283.
Rosa J. Oliver S. Mitsuhashi M, et al. Altered Kinetics of interlekin-6 and other inflammatory mediators during exersise in children with type 1 diabetes. Journal of Investigative Medicine 2008; 56 (4): 701-713.
Rodríguez M, Cejas J, Esteves G, Minuchín G, Rodríguez Vitoria JM, Cruzado V, Quesada I, Castro C. Impacto del ejercicio prolongado en la albuminuria y estado inflamatorio en maratonistas con diabetes mellitus tipo 1. Rev ALAD 2015; 5(1)38-47.
Storino MA, Contreras MA, Rojano J, Serrano R, Nouel A. Complicaciones de la diabetes y su asociación con el estrés oxidativo: un viaje hacia el daño endotelial. Rev Colomb Cardiol 2014; 21 (6): 392-398.
Avogaro A, Albiero M, Menegazzo L, et al. Endothelial dysfunction in diabetes. The role of reparatory mechanisms. Diabetes Care 2011; 34(2):285-290.
Fuchsjager-Mayrl G, Pleiner J, Wiesinger GF, et al. Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care 2002; 25 (10) 1795-1801.
Narendran P, Solomon TP, Kennedy A, et al. The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes. Diabetologia 2015; 58:10-18.
Oram RA, Jones AG, Rachel EJ, et al. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 2014; 57:187-191.
Martínez-Ramonde T , Alonso N, Cordido F, et al. Importance of exercise in the control of metabolic and inflammatory parameters at the moment of onset in type 1 diabetic subjects. Exp Clin Endocrinol Diabetes 2014; 122: 334-340.
Horton W, Subauste J. Care of the athlete with Type 1 diabetes mellitus: a clinical review. Int J Endocrinol Metab 2016; 14 (2).
Gómez AM, Gómez C, Aschner P, et al. Effects of performing morning vs afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy. Journal of Diabetes, Science and Technology 2015; 9(3), 619- 624.
Lifestyle Management. American Diabetes Association. Diabetes Care Jan 2017; 40 (Supplement 1) S33-S43. doi: 10.2337/dc17-S007.
Yardley JE, Hay J, Abou-Setta AM, Marks SD, McGavock J. A systematic review and meta-analysis of exercise interventions in adults with type 1 diabetes. Diabetes Res Clin Pract 2014; 106: 393-400.
Kennedy A, Nirantharakumar K, Chimen M, et al. Does exercise improve glycaemic control in type 1 diabetes? A systematic review and meta-analysis. PloS One 2013; 8: 58861.
Office of Disease Prevention and Health Promotion, U.S. Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans [Internet]. Disponible en http://www.health.gov/paguidelines/guidelines/ default.aspx. Acceso: octubre 2014.
Hanas R, Laffel L, Domenger C, et al. Exercise is associated with glycemic control and QoL in young persons with type 1 diabetes (T1D): the Global TEENs study. International Society for Pediatric and Adolescent Diabetes and Australasian Paediatric Endocrine Group 2015; Brisbane, QLD, Australia; Oct 7-10, 2015.
Rich L, Thompson C, Forbes A, Narendran P, Andrews R. Healthcare professionals have poor knowledge but high levels of confidence regarding exercise in type 1 diabetes. International Diabetes Federation, World Diabetes Congress; Vancouver, BC, Canada; Nov 30-Dec 4, 2015. Abstract 0449-PD.
The New PAR-Q+ and ePARmed-X+. Fecha de revisión: 25 de febrero de 2018. Disponible en: http://eparmedx.com/.
American Diabetes Association. Diabetes Care 2015; 38 (Suppl 1): S20-30.
Gawrecki A, Naskret D, Niedzwiecki P, et al. Higth-intensity exercise in men with type 1 diabetes and mode of insulin therapy. Int J Sports Med 2017 Apr; 38(4):329-335.
Bracken RM, West DJ, Bain SC. Pre-exercise insulin and carbohydrate strategies in the exercising T1DM Individual. En: Gallen I. Type 1 diabetes: clinical management of the athlete. Springer-Verlag London Limited 2012.
https://link.springer.com/book/10.1007/978-0-85729-754-9
Heise T, Bain SC, Bracken RM, et al. Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial. Diabetes Obes Metab 2016 Feb; 18(2):196-9.
Bally L, Kempf P, Zueger T, et al. Metabolic effects of glucose-fructose co-ingestion compared to glucose alone during exercise in type 1 diabetes. Nutrients 2017 Feb; 21, 9(2).
Shetty VB, Fournier PA, Davey RJ, ET AL. Effect of exercise intensity on glucose requirements to maintain euglycemia during exercise in type 1 diabetes. J Clin Endocrinol Metab 2016 Mar; 101(3):972-80.
Francescato MP, Stel G, Stenner E, et al. Prolonged exercise in type 1 diabetes: performance of a customizable algorithm to estimate the carbohydrate supplements to minimize glycemic imbalances. PLoS One. 2015 Apr 28; 10(4).
Buoite S, Assaloni R, Tonutti L, et al. Strategies used by patients with type 1 diabetes to avoid hypoglycemia in a 24×1-hour marathon: comparison with the amounts of carbohydrates estimated by a customizable algorithm. Can J Diabetes 2017 Apr; 41(2):184-189.
Riddell MC, Milliken J. Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study. Diabetes Technol Ther 2011 Aug; 13(8):819-25.
Zaharieva D, Yavelberg L, Jamnik V, et al. The effects of basal insulin suspension at the start of exercise on blood glucose levels during continuous vs circuit-based exercise in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Technol Ther 2017 Jun; 19(6):370-378.
Hernando-Pérez, MA. http://www.gbt.tfo.upm.es/Diabetes+technology. http://www.gbt.tfo.upm.es/Diabetes+technology. (En línea) Citado el: 24 de septiembre de 2017. Disponible en: http://www.gbt.tfo.upm.es/Diabetes+technology.
Bohn B, Herbst A, Pfeifer M, et al. Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients. Diabetes Care 2015; 38:1536-1543.
Makura C, Nirantharakumar K, Girling A, et al. Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes: retrospective analysis of the DCCT study. Endocrine Disorders 2013; 13: 37.
Basu R, Johnson M, Kudva Y, et al. Exercise, hypoglycemia, and type 1 diabetes. Diabetes Technology and Therapeutics 2014; 16:331-337.
Burr J, Shephard R, Riddell M. Physical activity in type 1 diabetes mellitus. Canadian Family Physician 2012; 58:533-535.
Vigersky R. The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus. Journal of Diabetes Science and Technology 2015; 9:320-330.
Sylvia L, Bernstein E, Hubbard-Keating L, Anderson H. A practical guide to measuring physical activity. J Acad Nutr Diet 2014;114:199-208.
Yilmaz T, Foster R , Yang H. Detecting vital signs with wearable wireless sensors Londres. Sensors 2010; 10: 0837-10862.
Dobkin B, Dorsch A. The promise of mHealth: daily activity monitoring and outcome assessments by wearable sensors. Los Angeles. Neurorehabil Neural Repair, 2011. 25. 788-798.
Aguilar-Cordero, MJ, Sánchez-López AM, Guisado-Barrilao R, et al. Descripción del acelerómetro como método para valorar la actividad física en los diferentes periodos de la vida; revisión sistemática. Nutrición Hospitalaria 2014; 29:1250-1261.
Dencker M, Andersen L. Accelerometer-measured daily physical activity related to aerobic fitness in children and adolescents. Journal of Sports Sciences 2011; 29: 887-895.
Goodwin MA, Harris JE, Hernández MA, et al. Blood lactate measurements and analysis during exercise: a guide for clinicians. Journal of Diabetes Science and Technology 2007; 1:558-569.
Dobkin B. Wearable motion sensors to continuously measure realworld activities. Current Opinion Neurology 2013; 26: 602-608.
Arsand E, Froisland D, Skrovseth S. Mobile health applications to assist patients with diabetes: lessons learned and design implications. Journal of Diabetes Science and Technology 2012; 6:1197- 1206.
Schiavon M, Dalla Man Ch, Kudva Y, et al. In silico optimization of basal insulin infusion rate during exercise: implication for artificial pancreas. Journal of Diabetes Science and Technology 2013; 7:1461-1469.
Admon G, Yitzhak-Weinstein Y, Falk B. et al. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus. Pediatrics 2004; 116:348-355.
Moniotte SM, Owen M, Barrea T, et al. Outcomes of algorithm-based modifications of insulinotherapy during exercise in MDI vs insulin pump-treated children with type 1 diabetes: Results from the TREAD-DIAB study. John Wiley & Sons 2016;1-9.
Yardley J, Iscoe K, Sigal R, et al. Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections an observational study of physically active type 1 diabetes patients. Diabetes Technology and Therapeutics 2013; 15:84-88.
Peters A, Ahmann A, Battelino T, et al. Diabetes technology continuous subcutaneous insulin infusion therapy and continuous glucose. Journal Clinical Endocrinology and Metabolism 2016; 101:1-17.
Heinemann L, Hompesch M. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs. American Diabetes Association. Diabetes Care 2015; 8: 6-13.
Brazg R, Klaff L, Parkin C, et al. Performance variability of seven commonly used clinical considerations for patients and providers self-monitoring of blood glucose systems. Journal of Diabetes Science and Technology 2013; 7:144-152.
Jendrike N, Baumstark A, Kamecke U, et al. ISO 15197: 2013 Evaluation of a measurement accuracy blood glucose monitoring system’s. Journal of Diabetes Science and Technology 2017; 00:1-2
Wojciechowski P, Ryś P, Lipowska A, et al. Efficacy and safety comparison of continuous of blood glucose in type 1 diabetes glucose monitoring and self monitoring. Polskie Archiwum Medycyny Wewnętrznej 2011; 121:333-343.
Taleb N, Emami A, Suppere C, et al. Comparison of two continuous glucose monitoring systems, dexcom G4 platinum and medtronic paradigm veo enlite system, at rest and during exercise. Mary Ann Liebert 2016; 18:1-7.
Adolfsson P, Nilsson S, Lindblad S. Continuous glucose monitoring system during physical exercise in adolescents with type 1 diabetes. Acta Pædiatrica 2011; Vol. 100:1603-1609.
Moser O, Mader J, Tschakert G, et al. Accuracy of continuous glucose monitoring (CGM) during continuous and high-intensity interval exercise in patients with type 1 diabetes mellitus. Nutrients 2016; 8:1-15.
Chassin LJ, Wilinska M, Hovorka, R. Intense exercise in type 1 diabetes: exploring the role of continuous glucose monitoring. Journal of Diabetes Science and Technology 2007; 1:570-573.
Garg SK, Akturk HK. Flash glucose monitoring: the future is here. Mary Ann Liebert 2017;19:1-2.
Dassau E, Renard E, Place J, et al. Intraperitoneal insulin delivery provides superior glycemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial páncreas in patients with type 1 diabetes: a pilot Study Francia : JDRF and National Institutes of Health, 2017.1-25.
De Leiva A, Hernando M. Telemedical artificial pancreas. Diabetes Care 2009; 32:211-215.
Lanzola G, Capozzi D, Serina, N, et al. Bringing the artificial pancreas home: telemedicine aspects. Journal of Diabetes Science and Technology 2011; 5:1381-1386.
Bergenstal R, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV, Kaufman FR. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 2016 Oct 4; 316(13):1407-1408.
Satish G, Weinzimer S, Tamborlane W, et al. Glucose outcomes with the in-home use in adolescents and adults with type 1 diabetes of a hybrid closed-loop insulin delivery system. Mary Ann Liebert 2017; 19:155-163.
Riddell M. Exercise and the development of the artificial pancreas: one of the more difficult series of hurdles. Journal of Diabetes Science and Technology; 2015. 9.
Taleb N, Emami A, Suppere C, et al. Efficacy of single-hormone and dual-hormone artificial pancreasduring continuous and interval exercise in adult patients with type1 diabetes: randomised controlled crossover trial. Diabetologia Springer 2016; 59:2561-2571.
Stenerson M, Cameron F, Payne SR, et al. The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes. Journal of Diabetes Science and Technology 2015; 9:80-85.
Dasanayake I, Bevier WC, Castorino K, et al. Early detection of physical activity for people with type 1 diabetes mellitus. Journal of Diabetes Science and Technology 2015; 9:1236-1245.
Manohar Ch,O’Keeffe DT, Hinshaw L, et al. Comparison of physical activity sensors and heart rate monitoring for real-time activity detection in type 1 diabetes and control subjects. Mary Ann Liebert 2013; 15:751-757.
Sandrine D, Schumacher M. Sensor monitoring of physical activity to improve glucose management in diabetic patients: a review. Sensors 2016; 16:1-13.
Jacobs P, Resalat N, Youssef J, et al. Incorporating an exercise detection, grading, and hormone dosing algorithmInto the artificial pancreas using accelerometry and heart rate. Journal of Diabetes Science and Technology 2015; 9: 1175-1184.
Turksoy K, Luz Paulino T, Dessi P, Zaharieva D, et al. Classification of physical activity: information to artificial pancreas. Journal of Diabetes Science and Technology, 2015.
Dovc K, Macedoni M, Bratina N, et al. Closed-loop glucose control in young people with type 1 diabetesduring and after unannounced physical activity: a randomised controlled crossover trial. Diabetologia 2017; 60:2157-2167.
Adolfsson P, Örnhagen H, Jend J, et al. The benefits of continuous glucose monitoring and a glucose monitoring schedule in individuals with type 1 diabetes during recreational diving. Journal of Diabetes Science and Technology; 2008. 2.
Turksoy K, Monforti C, Park M, et al. Use of wearable sensors and biometric variables in an artificial pancreas system. Sensors 2017; 17:1-17.
Bachmann S, Hess M, Martin-Diene E, et al. Nocturnal hypoglycemia and physical activity in children with diabetes: new insights by continuous glucose monitoring and accelerometry. Diabetes Care 2016; 39:95-96.
Ridell M. Ejercicio en DM1. San Diego. Key points in diabetes, 2017.
MacKnight JM, Mistry DJ, Green Pastors J, Holmes V, Rynders CA. The daily management of athletes with diabetes. Clin Sports Med 2009; 28: 479-495.
Mitchell JH, Haskell W, Snell P, Van Camp SP. Task Force 8: Classification of Sports. JACC 2005; 45(8):1364-1367.
Harris GD, White RD. Diabetes in the competitive athlete. Current Sports Medicine Reports 2012; 11(6): 309-315.
Draznin MB. Managing the adolescent athlete with type 1 diabetes mellitus. Pediatr Clin N Am 2010; 57:829-839.
Sherlock M, Thompson C. Diabetes and specific sports. En: Nagi D. Excersie and sport in diabetes. 2º Ed, England, John Wiley & Sons, Ltd., 2005. 142-159.
Robertson K, Riddell MC, Guinhouya BC, et al. ISPAD (International Society for Pediatric and Adolescent Diabetes) Exercise in children and adolescents with diabetes Pediatric Diabetes 2014; 15 (Suppl. 20): 203-223.
MacMillan F, Kirk A, Mutrie N, Matthews L. et al. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatric Diabetes 2013;1-15.
Krystyna A, Matyka S, AnnanI F. Physical activity in childhood diabetes. En: Gallen, I. Type 1 diabetes, clinical management of the athlete. British Library Cataloguing in Publication Data; 2012. 73-99.
Quirk H, Blake H, Dee B, et al. You can't just jump on a bike and go. A qualitative study exploring parents' perceptions of physical activity in children with type 1 diabetes. Rev. BMC Pediatrics; 2014.14:12. 313.
Guías de práctica clínica para el manejo de la diabetes tipo 1. Expertos de la Sociedad Argentina de Diabetes.
Helen Quirk, Holly Blake, Beatrice Dee, et al. Having diabetes shouldn't stop them. Healthcare professionals' perceptions of physical activity in children with type 1 diabetes, Rev. BMC Pediatrics 2015; 15: 6.68.
Pivovarov JA, Taplin CE, Riddell MC. Current perspectives on physical activity and exercise for youth with diabetes, Rev. Pediatric Diabetes 2015; 16:4. 42-55.
Mutlu EK, Mutlu C, Taskiran H, et al. Association of physical activity level with depression, anxiety, and quality of life in children with type 1 diabetes mellitus. Rev. Journal of Pediatric Endocrinology & Metabolism 2015, 28:11-12.1273-8.
Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016; 39:2065-2079.
Makura C, Nirantharakumar K, Girling A, Saravanan P, Narendran P. Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes: retrospective analysis of the DCCT study. BMC Endocrine Disorders 2013; 13: 37.
Bohn BH, Pfeifer M, Krakow D, et al; for the DPV. Initiative, impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients. Diabetes Care 2015; 38: 1536-1543.
Chimen M, Kennedy A, et al. What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 2012; 55: 542-551.
Novials A. Ampudia F. Diabetes y ejercicio. Grupo de Trabajo de Diabetes y Ejercicio de la Sociedad Española de Diabetes (SED), 2006.
Riebe D, Franklin B, Thompson P, et al. Updating ACSMs recommendations for exercise preparticipation health screening. Official Journal of the American College of Sports Medicine 2015; 2473-2479.
Robinson-Cohen C, Littman A, Duncan GE, et al. Physical activity and change in estimated GFR among Persons with CKD. J Am Soc Nephrol 2014; 25:399-406.
Waden J, Forsblom C, Thorn L, et al. Physical activity and diabetes complications in patients with type 1 diabetes. The Finnish Diabetic Nephropathy (FinnDiane) Study. Diabetes Care 2008, 31(2): 230-232.
Waden J, Tikkanen H, Forsblom C, et al. Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study. Diabetologia 2015; 58:929-936.
Carney E. Intensive exercise associated with reduced risk of diabetic nephropathy in patients with type 1 diabetes mellitus. Nature Reviews Nephrology 2015; 11:198.
Rodríguez M, Minuchín G, et al. Microalbuminuria post maratón (42,195 km) en diabéticos tipo 1. Revista de la Sociedad Argentina de Diabetes 2009; 43(3):121-126.
Balducci S, Iacobellis G, Parisi L, et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications 2006; 20:216-223.
Colberg S, Vinik A. Exercising with peripheral or autonomic neuropathy: what health care providers and diabetic patients need to know. The Physician and Sports Medicine 2014; 42(1): p. 15-23.
Moon HY, Becke A, Berron D, et al. Running-induced systemic cathepsin B secretion is associated with memory function. Cell Metabolism 2016; 24: 332-340.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
